During the medical trial encounter with Xyrem in narcolepsy/cataplexy patients at therapeutic doses, two sufferers claimed panic and one claimed insomnia subsequent abrupt discontinuation with the termination on the clinical trial; in The 2 individuals with anxiousness, the frequency of cataplexy had elevated markedly at the same time.Folks who alr